X4 Pharmaceuticals, Inc. (XFOR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.72
Day's range
$4.16

X4 Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MORGAN STANLEY 08/13/2026 9.46 M $44.18 M   -0.06% 7.49%
FMR LLC 08/13/2026 8.32 M $38.86 M   2.69% 6.59%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 08/14/2026 7.97 M $37.21 M   0.00% 6.31%
PERCEPTIVE ADVISORS LLC 08/14/2026 7.93 M $37.05 M   17.75% 6.28%
SATURN V CAPITAL MANAGEMENT LLC 08/14/2026 6.97 M $32.57 M   8.00% 5.52%
EMPERY ASSET MANAGEMENT, LP 08/11/2026 6.93 M $32.37 M   -22.51% 5.49%
DEEP TRACK CAPITAL, LP 08/14/2026 5.88 M $27.45 M   -7.27% 4.65%
BLACKROCK, INC. 08/07/2026 5.55 M $25.94 M   358.40% 4.40%
KALEHUA CAPITAL MANAGEMENT LLC 08/19/2026 3.72 M $17.39 M   0.00% 2.95%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.72 M $17.35 M   6.24% 2.94%
ROSALIND ADVISORS, INC. 08/14/2026 3.21 M $15.01 M   0.00% 2.54%
BRAIDWELL LP 08/14/2026 2.92 M $13.65 M   -10.70% 2.31%
BLACKSTONE INC. 08/14/2026 2.68 M $12.52 M   0.00% 2.12%
TRAILS EDGE CAPITAL PARTNERS, LP 08/14/2026 2.57 M $12.01 M   0.00% 2.04%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 2.45 M $11.44 M   0.00% 1.94%
BVF INC/IL 08/14/2026 2.23 M $10.43 M   0.00% 1.77%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.10 M $9.80 M   123.26% 1.66%
VR ADVISER, LLC 08/14/2026 1.93 M $9.03 M   485.21% 1.53%
SAMSARA BIOCAPITAL, LLC 08/14/2026 1.40 M $6.52 M   -23.85% 1.10%
STATE STREET CORP 08/07/2026 1.30 M $6.05 M   221.17% 1.03%
WOODLINE PARTNERS LP 08/14/2026 1.00 M $4.68 M   0.00% 0.79%
GOLDMAN SACHS GROUP INC 08/14/2026 916.54 K $4.28 M   3.90% 0.73%
NORTHERN TRUST CORP 08/13/2026 652.85 K $3.05 M   266.29% 0.52%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 572.04 K $2.67 M   18.99% 0.45%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 542.13 K $2.53 M   100.00% 0.43%
VERDAD ADVISERS, LP 08/14/2026 352.09 K $1.64 M   100.00% 0.28%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 263.26 K $1.23 M   294.41% 0.21%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 263.26 K $1.23 M   100.00% 0.21%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 250.30 K $1.17 M   100.00% 0.20%
CAPTION MANAGEMENT, LLC 08/14/2026 250.00 K $1.17 M   100.00% 0.20%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 224.99 K $1.05 M   -32.90% 0.18%
BANK OF NEW YORK MELLON CORP 08/06/2026 196.34 K $916.91 K   100.00% 0.16%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 145.00 K $677.15 K   0.00% 0.11%
NUVEEN, LLC 08/11/2026 107.39 K $501.51 K   100.00% 0.09%
INVESCO LTD. 08/14/2026 96.77 K $451.93 K   384.64% 0.08%
ALPS ADVISORS INC 07/29/2026 95.73 K $447.04 K   100.00% 0.08%
RHUMBLINE ADVISERS 08/12/2026 95.08 K $444.02 K   100.00% 0.08%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 87.28 K $407.61 K   -14.93% 0.07%
DEUTSCHE BANK AG\ 08/07/2026 78.89 K $368.39 K   100.00% 0.06%
GSA CAPITAL PARTNERS LLP 08/06/2026 76.31 K $356.00 K   100.00% 0.06%
AMERICAN CENTURY COMPANIES INC 08/12/2026 74.80 K $349.29 K   100.00% 0.06%
CITIGROUP INC 08/03/2026 70.11 K $327.42 K   96.04% 0.06%
WELLS FARGO & COMPANY/MN 08/14/2026 67.71 K $316.22 K   100.00% 0.05%
PALUMBO WEALTH MANAGEMENT LLC 08/12/2026 67.12 K $313.43 K   -48.77% 0.05%
SQUAREPOINT OPS LLC 08/14/2026 67.08 K $313.25 K   100.00% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 66.38 K $310.00 K   100.00% 0.05%
UBS GROUP AG 08/13/2026 58.04 K $271.06 K   -78.29% 0.05%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 51.80 K $241.91 K   100.00% 0.04%
METLIFE INVESTMENT MANAGEMENT, LLC 08/14/2026 47.97 K $224.02 K   100.00% 0.04%
BANK OF AMERICA CORP /DE/ 08/14/2026 46.86 K $218.84 K   -68.90% 0.04%

X4 Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 137 institutional investors and hedge funds held shares of X4 Pharmaceuticals Inc. The most heavily invested institutionals were:

MORGAN STANLEY: 9.46 M

FMR LLC: 8.32 M

Bain Capital Life Sciences Investors, LLC: 7.97 M

PERCEPTIVE ADVISORS LLC: 7.93 M

Saturn V Capital Management LLC: 6.97 M

Empery Asset Management, LP: 6.93 M

76.13% of X4 Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 111.34 M shares in the last 24 months. This purchase volume represents approximately $462.08 M in transactions.